- Report
- August 2023
- 150 Pages
North America
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2021
- 500 Pages
United States
From €2316EUR$2,400USD£1,987GBP
- Report
- October 2022
- 177 Pages
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- October 2022
- 174 Pages
North America
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- October 2022
- 181 Pages
Middle East, Africa
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- October 2022
- 202 Pages
Europe
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- July 2022
- 255 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 90 Pages
South Korea
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
India
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 90 Pages
France
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Russia
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Mexico
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 70 Pages
Germany
From €4585EUR$4,750USD£3,933GBP
Levemir is a medication used to treat endocrine and metabolic disorders, such as diabetes. It is a long-acting insulin analog, meaning it is a synthetic form of insulin that is designed to mimic the body's natural insulin production. Levemir is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is typically taken once or twice daily, depending on the individual's needs. Levemir is available in both vials and pens, and is typically injected under the skin.
Levemir is a popular medication for treating endocrine and metabolic disorders, and is widely available in many countries. It is manufactured by Novo Nordisk, a Danish pharmaceutical company, and is available in both generic and branded forms. Other companies that produce Levemir include Sanofi, Eli Lilly, and Biocon. Show Less Read more